PRAXBIND
Active Ingredient: IDARUCIZUMAB
Product Overview
About PRAXBIND
PRAXBIND is a medication used to reverse the anticoagulant effects of dabigatran etexilate, a direct oral anticoagulant (DOAC). It is a monoclonal antibody fragment that selectively binds to dabigatran etexilate, thereby neutralizing its anticoagulant activity.
Key Benefits & Uses
- Reversal of dabigatran etexilate-induced anticoagulation in patients with acute major bleeding or requiring urgent surgery
- Reversal of dabigatran etexilate-induced anticoagulation in patients with life-threatening bleeding
- Reversal of dabigatran etexilate-induced anticoagulation in patients with severe bleeding
Active Ingredient & Action
PRAXBIND contains idarucizumab, a humanized monoclonal antibody fragment that selectively binds to dabigatran etexilate with high affinity. This binding reaction results in the neutralization of dabigatran etexilate's anticoagulant activity, thereby reversing its effects.
Important Notes
PRAXBIND should only be administered by healthcare professionals in a clinical setting. It is essential to follow the recommended dosing and administration guidelines to ensure effective reversal of dabigatran etexilate-induced anticoagulation. Patients with a history of hypersensitivity reactions to idarucizumab or other monoclonal antibodies should not receive PRAXBIND.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.